Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exogenously regulated stem cell-mediated gene therapy for bone regeneration.

I K Moutsatsos1, G Turgeman, S Zhou

  • 1Molecular Pathology Laboratory, Hebrew University-Hadassah Medical and Gene Therapy Center, Jerusalem, Israel.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|April 26, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effective field theory for lattice nuclei.

Physical review letters·2015
Same author

Effects of three-nucleon forces and two-body currents on Gamow-Teller strengths.

Physical review letters·2015
Same author

Strategies for regenerative mesenchymal stem cell therapies of skeletal disorders: pathways to tendon formation.

Journal of stem cells & regenerative medicine·2014
Same author

Oxidative stress protection by novel telomerase activators in mesenchymal stem cells derived from healthy and diseased individuals.

Current molecular medicine·2013
Same author

BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells.

Gene therapy·2012
Same author

Chiral two-body currents in nuclei: Gamow-Teller transitions and neutrinoless double-beta decay.

Physical review letters·2011

This study presents a novel stem cell therapy for bone regeneration. Genetically engineered mesenchymal stem cells (MSCs) controlled by doxycycline enable precise regulation of bone healing and angiogenesis.

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Gene Therapy

Background:

  • Controlled transgene expression is crucial for gene therapy and biological process monitoring.
  • Mesenchymal stem cells (MSCs) are promising for regenerative medicine applications.

Purpose of the Study:

  • To develop a regulated stem cell-based system for controlling bone regeneration.
  • To investigate the use of genetically engineered MSCs with a tetracycline-regulated system for bone healing.

Main Methods:

  • Genetically engineered MSCs harboring a tetracycline-regulated expression vector encoding human BMP-2 were created.
  • The effect of doxycycline on hBMP-2 expression, MSC osteogenic differentiation, bone formation, and angiogenesis was assessed in vitro and in vivo.

Related Experiment Videos

Main Results:

  • Doxycycline effectively controlled hBMP-2 expression and MSC osteogenic differentiation.
  • In vivo, doxycycline administration regulated bone formation and regeneration.
  • Induced hBMP-2 expression in MSCs led to increased angiogenesis alongside bone formation.

Conclusions:

  • Regulated gene expression in MSCs offers a method to control bone healing.
  • This tetracycline-inducible system provides a controllable platform for regenerative medicine strategies.
  • The findings highlight the potential of gene-modified MSCs for enhanced bone regeneration and angiogenesis.